6.
Chen Y, Chen B, Wu T, Zhou F, Xu F
. Cryo-EM structure of human κ-opioid receptor-Gi complex bound to an endogenous agonist dynorphin A. Protein Cell. 2023; 14(6):464-468.
PMC: 10246719.
DOI: 10.1093/procel/pwac033.
View
7.
Hassanien S, Bassman J, Perrien Naccarato C, Twarozynski J, Traynor J, Iula D
. In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis. Drug Test Anal. 2020; 12(8):1212-1221.
PMC: 8034271.
DOI: 10.1002/dta.2822.
View
8.
Sturaro C, Malfacini D, Argentieri M, Djeujo F, Marzola E, Albanese V
. Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands. Front Pharmacol. 2022; 13:873082.
PMC: 9068900.
DOI: 10.3389/fphar.2022.873082.
View
9.
Tan L, Yan W, McCorvy J, Cheng J
. Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. J Med Chem. 2018; 61(22):9841-9878.
DOI: 10.1021/acs.jmedchem.8b00435.
View
10.
Tian W, Chen C, Lei X, Zhao J, Liang J
. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018; 46(W1):W363-W367.
PMC: 6031066.
DOI: 10.1093/nar/gky473.
View
11.
Portoghese P
. Relationships between stereostructure and pharmacological activities. Annu Rev Pharmacol. 1970; 10:51-76.
DOI: 10.1146/annurev.pa.10.040170.000411.
View
12.
Zhuang Y, Wang Y, He B, He X, Zhou X, Guo S
. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor. Cell. 2022; 185(23):4361-4375.e19.
DOI: 10.1016/j.cell.2022.09.041.
View
13.
Sakkiah S, Guo W, Pan B, Ji Z, Yavas G, Azevedo M
. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations. Front Chem. 2021; 8:622632.
PMC: 7813797.
DOI: 10.3389/fchem.2020.622632.
View
14.
Selvaraj C, Sakkiah S, Tong W, Hong H
. Molecular dynamics simulations and applications in computational toxicology and nanotoxicology. Food Chem Toxicol. 2017; 112:495-506.
DOI: 10.1016/j.fct.2017.08.028.
View
15.
Lutz P, Kieffer B
. Opioid receptors: distinct roles in mood disorders. Trends Neurosci. 2012; 36(3):195-206.
PMC: 3594542.
DOI: 10.1016/j.tins.2012.11.002.
View
16.
Mollereau C, Parmentier M, Mailleux P, Butour J, Moisand C, Chalon P
. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 1994; 341(1):33-8.
DOI: 10.1016/0014-5793(94)80235-1.
View
17.
Baker Rogers J, Higa G
. Spoken and Unspoken Matters Regarding the Use of Opioids in Cancer. J Pain Res. 2022; 15:909-924.
PMC: 8994621.
DOI: 10.2147/JPR.S349107.
View
18.
Han J, Zhang J, Nazarova A, Bernhard S, Krumm B, Zhao L
. Ligand and G-protein selectivity in the κ-opioid receptor. Nature. 2023; 617(7960):417-425.
PMC: 10172140.
DOI: 10.1038/s41586-023-06030-7.
View
19.
Feng Y, He X, Yang Y, Chao D, Lazarus L, Xia Y
. Current research on opioid receptor function. Curr Drug Targets. 2011; 13(2):230-46.
PMC: 3371376.
DOI: 10.2174/138945012799201612.
View
20.
Yang D, Zhou Q, Labroska V, Qin S, Darbalaei S, Wu Y
. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther. 2021; 6(1):7.
PMC: 7790836.
DOI: 10.1038/s41392-020-00435-w.
View